• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchTravere Therapeutics
    Picture of Travere Therapeutics logo

    TVTX — Travere Therapeutics News Story

    $52.790.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    • Market Cap
      $4.98bn
    • Enterprise Value
      $5.09bn
    • Revenue
      $490.73m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • TVTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    TVTX Dividends
    All News

    NASDAQ RESUMED AT 07:55 AM

    Picture of Travere Therapeutics logoTravere Therapeutics
    14/04/2026 12:55
    NASDAQ RESUMED  TVTX.O  AT 07:55 AM
    

    Recent news on Travere Therapeutics

    See all news
    • Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      12/10/2026 23:20
    • Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS

      23/09/2026 12:05
    • Brief: Travere Therapeutics Announces Planned Chief Executive Officer Transition

      21/09/2026 21:18
    • Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      11/09/2026 22:02
    • Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

      12/08/2026 22:47

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.